Like I said before
1)Ath has to get a biotech name for their drug from the WHO
2) Drug manufacture in the US
3) FDA … accelerated approval..
4)Partner … a) Distribution
. b) continuation Phase 3
All takes time….
I see no problems now that we have approx $51 million in the BANk..
With a MC over $100 million
Greatest risk of AD is poor control of ferroptosis, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.002(12.5%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.5¢ | 1.4¢ | $211.2K | 15.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 5845021 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 10843726 | 17 |
View Market Depth
| Last trade - 10.50am 29/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |